Correlation Between Alnylam Pharmaceuticals and Meta Platforms
Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and Meta Platforms at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and Meta Platforms into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alnylam Pharmaceuticals and Meta Platforms, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and Meta Platforms and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of Meta Platforms. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and Meta Platforms.
Diversification Opportunities for Alnylam Pharmaceuticals and Meta Platforms
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alnylam and Meta is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and Meta Platforms in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Meta Platforms and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with Meta Platforms. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Meta Platforms has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and Meta Platforms go up and down completely randomly.
Pair Corralation between Alnylam Pharmaceuticals and Meta Platforms
If you would invest 16,949 in Meta Platforms on January 26, 2024 and sell it today you would earn a total of 0.00 from holding Meta Platforms or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 4.55% |
Values | Daily Returns |
Alnylam Pharmaceuticals vs. Meta Platforms
Performance |
Timeline |
Alnylam Pharmaceuticals |
Meta Platforms |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Alnylam Pharmaceuticals and Meta Platforms Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alnylam Pharmaceuticals and Meta Platforms
The main advantage of trading using opposite Alnylam Pharmaceuticals and Meta Platforms positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, Meta Platforms can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Meta Platforms will offset losses from the drop in Meta Platforms' long position.Alnylam Pharmaceuticals vs. Terns Pharmaceuticals | Alnylam Pharmaceuticals vs. Amylyx Pharmaceuticals | Alnylam Pharmaceuticals vs. Acumen Pharmaceuticals |
Meta Platforms vs. Meta Platforms | Meta Platforms vs. Alphabet Inc Class A | Meta Platforms vs. Twilio Inc | Meta Platforms vs. Snap Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |